PROTECT ACCESS AND INNOVATION

Faces of California Biomedical Innovation is a campaign that brings the voices of patients impacted by the biomedical community in California to the forefront. Leading the way, patient voices make it clear that the biomedical sector and the innovative treatments and medtech being developed in it, are essential to a healthier California and world.

Faces of California Biomedical Innovation showcases how people in California are being impacted by life-saving treatments coming out the of the California biomedical industry.

Share Your Story

 

One way to advocate to policymakers in Sacramento and Washington D.C. is for them to hear more stories of how the biomedical community has impacted lives. Share how the biomedical innovation in California has been critical to your wellbeing below. Together, we can continue protecting biomedical innovation in California and around the world.


It is incredibly rewarding to call companies like @LillyPad members of CLSA.

Innovation, collaboration, & determination have defined the fight against the COVID pandemic....and innovation is winning.

Science always wins.

Thank you!! https://t.co/JUZ4gnmaw4
Eli Lilly and Company @LillyPad
Lilly has reached an agreement with the U.S. government to provide an investigational neutralizing antibody for the treatment of mild to moderate #COVID19 illness in high-risk patients, pending emergency use authorization. Read more: https://t.co/39rYMMVM3Q https://t.co/VxEzhtIPsj

CLSA - California Life Sciences Association
CLSA - California Life Sciences Association
Fantastic perspective from CLSA member company @Genentech about the threat to innovation from the MFN executive order recently issued by the white house.

Breakthrough science demands equally bold policy — and pricing — solutions https://politi.co/3n6Dfdq via @politico